Keywords: stada, extends, voucher, program, rheumatrex, pharmaceuticals, subsidiary

STADA extends voucher program for Rheumatrex

Article | 13 December 2004

Print This

STADA Pharmaceuticals, the US subsidiary of Germany's STADA Arzneimittel, says that it has extended its Trial Script voucher program for ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in